Package 50458-541-60

Brand: invokamet

Generic: canagliflozin and metformin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 50458-541-60
Digits Only 5045854160
Product NDC 50458-541
Description

60 TABLET, FILM COATED in 1 BOTTLE (50458-541-60)

Marketing

Marketing Status
Marketed Since 2014-08-08
Brand invokamet
Generic canagliflozin and metformin hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3ce5755e-f0a3-692b-e063-6294a90a3c1f", "openfda": {"upc": ["0350458543605", "0350458541601"], "unii": ["0SAC974Z85", "786Z46389E"], "rxcui": ["1545150", "1545156", "1545157", "1545159", "1545161", "1545163", "1545164", "1545166", "1810997", "1810999", "1811002", "1811003", "1811006", "1811007", "1811010", "1811011"], "spl_set_id": ["6868666b-c25e-40d1-9d1f-306bbe9390c1"], "manufacturer_name": ["Janssen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (50458-541-60)", "package_ndc": "50458-541-60", "marketing_start_date": "20140808"}], "brand_name": "INVOKAMET", "product_id": "50458-541_3ce5755e-f0a3-692b-e063-6294a90a3c1f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Biguanide [EPC]", "Biguanides [CS]", "P-Glycoprotein Inhibitors [MoA]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "50458-541", "generic_name": "canagliflozin and metformin hydrochloride", "labeler_name": "Janssen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INVOKAMET", "active_ingredients": [{"name": "CANAGLIFLOZIN", "strength": "50 mg/1"}, {"name": "METFORMIN HYDROCHLORIDE", "strength": "1000 mg/1"}], "application_number": "NDA204353", "marketing_category": "NDA", "marketing_start_date": "20140808", "listing_expiration_date": "20261231"}